Literature DB >> 2033261

Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.

M J Janusz1, N S Doherty.   

Abstract

The granule proteases of human neutrophils are thought to be responsible for the connective tissue destruction associated with certain inflammatory diseases. Using a model system for the degradation of a macromolecular connective tissue substrate, purified neutrophil elastase and cathepsin G were both individually able to degrade cartilage matrix proteoglycan and this degradation was blocked by the appropriate specific inhibitors. Neutrophil granule lysate also produced cartilage matrix degradation but little inhibition of degradation occurred when either elastase or cathepsin G inhibitor was used alone. However, a combination of elastase and cathepsin G inhibitors each at 100 microM or each at 10 microM blocked cartilage matrix degradation by 89% +/- 1 and 65% +/- 9 (mean +/- SEM, n = 3), respectively. The magnitude of the cartilage degradation mediated by neutrophil lysate, and its sensitivity to specific inhibitors, was reproduced using purified elastase and cathepsin G at the concentrations at which they are present in neutrophil lysate. Human neutrophils stimulated with opsonized zymosan degraded cartilage matrix in a dose-dependent manner in the presence of serum antiproteases. Supernatants from stimulated neutrophils cultured in the presence of serum did not degrade cartilage matrix, indicating that neutrophil mediated degradation in the presence of serum was confined to the protected subjacent region between the inflammatory cell and the substratum. A combination of elastase and cathepsin G inhibitors each at 500 microM or each at 100 microM blocked subjacent cartilage matrix degradation by stimulated human neutrophils by 91% +/- 3 and 54% +/- 8 (mean +/- SEM, n = 5), respectively, whereas either the elastase or cathepsin G inhibitor alone was much less effective. These studies demonstrate that neutrophil-mediated cartilage matrix degradation is produced primarily by elastase and cathepsin G. Furthermore, these results support the hypothesis that inflammatory neutrophils form zones of close contact with substratum that exclude serum antiproteases and that this subjacent degradation of cartilage matrix by stimulated neutrophils can be blocked by a combination of synthetic elastase and cathepsin G inhibitors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033261

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Cathepsin G: the significance in rheumatoid arthritis as a monocyte chemoattractant.

Authors:  Junya Miyata; Kenji Tani; Keiko Sato; Shinsaku Otsuka; Tomoyuki Urata; Battur Lkhagvaa; Chiyuki Furukawa; Nobuya Sano; Saburo Sone
Journal:  Rheumatol Int       Date:  2006-09-15       Impact factor: 2.631

Review 2.  Neutrophil elastase inhibitors.

Authors:  William C Groutas; Dengfeng Dou; Kevin R Alliston
Journal:  Expert Opin Ther Pat       Date:  2011-01-16       Impact factor: 6.674

3.  Effects of interleukin-6 (IL-6) and transforming growth factor-beta (TGF-beta) on neutrophil elastase release.

Authors:  U Bank; D Reinhold; D Kunz; H U Schulz; C Schneemilch; W Brandt; S Ansorge
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

4.  Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide.

Authors:  Jean-Pierre Lévesque; Jean Hendy; Yasushi Takamatsu; Paul J Simmons; Linda J Bendall
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

5.  The inhibitory effects of antirheumatic drugs on the activity of human leukocyte elastase and cathepsin G.

Authors:  J Steinmeyer; D A Kalbhen
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

6.  Degradation of endothelial cell matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H2O2-chloride system.

Authors:  S J Klebanoff; M G Kinsella; T N Wight
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

7.  Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.

Authors:  P Renesto; V Balloy; T Kamimura; K Masuda; A Imaizumi; M Chignard
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

8.  Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits.

Authors:  A Matsukawa; S Ohkawara; T Maeda; K Takagi; M Yoshinaga
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

9.  Poly(ethylene glycol)-containing hydrogels promote the release of primary granules from human blood-derived polymorphonuclear leukocytes.

Authors:  Hannah Caitlin Cohen; Tyler Jacob Lieberthal; W John Kao
Journal:  J Biomed Mater Res A       Date:  2014-02-13       Impact factor: 4.396

10.  Pharmacological activity of the C-terminal and N-terminal domains of secretory leukoprotease inhibitor in vitro.

Authors:  K Masuda; T Kamimura; K Watanabe; T Suga; M Kanesaki; A Takeuchi; A Imaizumi; Y Suzuki
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.